Notable Studies: Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans Also Known As: UNII-62RC32V9N7, 62RC32V9N7 Research Applications: Growth hormone deficiency Body composition Sleep quality
Unveiling Semaglutide and Embracing a Dynamic Duo (Chapter 5) Introduction Over the years, the adoption of low carbohydrate eating plans has gained significant popularity due to their potential health benefits
Canagliflozin Moving away from the GLP-1 receptor agonists, Canagliflozin (Invokana) is an SGLT2 inhibitor
Healthcare professionals should monitor nutritional status, functional capacity, and encourage appropriate physical activity in patients using GLP-1 medications for weight management
2023YFE0209500)
Although diabetic subjects treated with DPP4 inhibitors exhibited modest reductions in markers of bone turnover (222), the available data examining putative changes in bone density or fracture rates are not sufficient for firm conclusions to be drawn